Balyasny Asset Management
TRDA icon

Balyasny Asset Management’s Entrada Therapeutics TRDA Stock Holding History

Balyasny Asset Management’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,132
Closed -$164K – 2650
2022
Q4 		$164K Buy
+12,132
New +$164K ﹤0.01% 1731